Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spruce Biosciences Inc (NQ: SPRB )

1.675 -0.025 (-1.48%)
Streaming Delayed Price Updated: 11:53 AM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,913
Open 1.666
Bid (Size) 1.680 (1)
Ask (Size) 1.690 (1)
Prev. Close 1.700
Today's Range 1.666 - 1.700
52wk Range 1.250 - 11.51
Shares Outstanding 23,492,873
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. 
Via Benzinga
74 Biggest Movers From Yesterday
Gainers 
Via Benzinga

Performance

YTD
-63.51%
-63.51%
1 Month
+7.37%
+7.37%
3 Month
-17.90%
-17.90%
6 Month
-57.27%
-57.27%
1 Year
-84.90%
-84.90%

More News

Read More
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Spruce Biosciences to Participate in June Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference
From Spruce Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences to Participate in May Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Appoints Libbie Mansell, Ph.D., M.B.A., R.A.C., as Chief Regulatory and Quality Officer
From Spruce Biosciences, Inc.
Via Business Wire
Where Spruce Biosciences Stands With Analysts
Via Benzinga
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer
From Spruce Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Spruce Biosciences to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
From Spruce Biosciences, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
23 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
From Spruce Biosciences, Inc.
Via Business Wire
18 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.